Status:

COMPLETED

Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures

Lead Sponsor:

Cognizance Biomarkers, LLC

Collaborating Sponsors:

University of Pennsylvania

Conditions:

Epilepsy

Eligibility:

All Genders

12+ years

Brief Summary

The primary goal of this observational study is to establish the accuracy of CNS-specific Assay for Recurrent Paroxysmal Events (CARPE) as a diagnostic blood test for epilepsy. The target population i...

Eligibility Criteria

Inclusion

  • Male/female patients aged 12 and older
  • Evaluation in at least one of the following settings:
  • Newly referred to the University of Pennsylvania Penn Epilepsy Center. These patients may not have completed any diagnostic evaluation at Penn, other than an initial physician consultation, prior to enrollment and must agree to allow the study team to collect records regarding their diagnostic evaluations (including EEG). Diagnostic evaluations may take place at Penn or outside sites
  • All patients who are admitted to the University of Pennsylvania for continuous video EEG (cVEEG) monitoring

Exclusion

  • Patients who, in the opinion of the investigator or the patients neurologist, are unable to give Informed Consent due to mental impairment or any other reason AND do not have a LAR who can give Informed Consent on their behalf. Patients aged 12-17 (inclusive) must provide assent if they are mentally capable of doing so, and must also have a caregiver who provides Informed Consent on their behalf
  • Patients who, in the opinion of their neurologist at the University of Pennsylvania, are not good candidates for donating blood for any reason

Key Trial Info

Start Date :

July 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 6 2018

Estimated Enrollment :

371 Patients enrolled

Trial Details

Trial ID

NCT02269397

Start Date

July 1 2013

End Date

December 6 2018

Last Update

July 31 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104